IRVINE, Calif.--(BUSINESS WIRE)--California Stem Cell, Inc. (CSC) has secured Series A financing from private investors. Proceeds will be used to expand its laboratory and manufacturing facilities here, allowing mass production of FDA compliant cells and pre-clinical development of treatments for cardiac and central nervous system disorders.
